Physician

Erin R Macrae, MD

According to 2025 Medicare claims, Erin Macrae, MD (NPI: 1033273040) practices medical oncology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is COLUMBUS ONCOLOGY ASSOCIATES INC (NPI: 1790875656; TIN: 311211874) and primary practice location at 43214-4359. Macrae is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Macrae's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 379 traditional Medicare patients, billed 85,666 HCPCS/CPT codes, and received $1,055,222 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,377 prescription claims across 192 beneficiaries totaling $1,688,924 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 42 claims. Open Payments data shows 3 records totaling $13. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $196,912 to $1,055,222. Similarly, Part D prescription costs have risen steadily, from $114,726 to $1,688,924. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,099 to $1,975.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	146	17,403	$196,912
2016	256	45,905	$662,880
2017	305	67,443	$606,740
2018	343	68,262	$596,797
2019	363	97,032	$969,994
2020	282	66,389	$589,970
2021	377	71,073	$726,019
2022	436	103,195	$1,027,120
2023	381	91,820	$854,607
2024	379	85,666	$1,055,222

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	101	372	$114,726
2016	155	876	$253,284
2017	185	1,229	$500,033
2018	195	1,247	$924,628
2019	191	1,208	$1,269,047
2020	184	1,089	$1,628,787
2021	191	1,200	$1,358,260
2022	212	1,345	$1,364,397
2023	193	1,237	$1,348,383
2024	192	1,377	$1,688,924

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$729
2016	N/R	105	$5,492
2017	N/R	60	$1,496
2018	N/R	41	$1,014
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	54	$2,048
2023	N/R	24	$1,334
2024	N/R	42	$1,975

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	172	437	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	105	122	$54
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	62	127	$43
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	205	394	$12
J1100	Injection, dexamethasone sodium phosphate, 1 mg	56	1,754	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	14	392	$289,991
Revlimid	Lenalidomide	11	308	$233,330
Imbruvica	Ibrutinib	12	336	$197,779
Abiraterone Acetate	Abiraterone Acetate	46	1,230	$71,368
Eliquis	Apixaban	37	1,980	$38,032

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	22	$1,660
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	20	$315

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$13	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$9,000	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Erin R. Macrae, MD?

Tedicare shows public-source Medicare data for Erin R. Macrae, MD (NPI 1033273040), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Erin R. Macrae, MD have ACO affiliation data?

Erin R. Macrae, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Erin R. Macrae, MD?

Erin R. Macrae, MD is linked to COLUMBUS ONCOLOGY ASSOCIATES INC (billing NPI 1790875656) in the available physician profile data.

Does Erin R. Macrae, MD have Open Payments data?

Erin R. Macrae, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.